Lipoprotein(a) levels and recorded post-test changes in lipid-lowering therapy in a large real-world Polish cohort
Elevated lipoprotein(a) [Lp(a)] is a recognized cardiovascular risk factor, but its association with subsequent lipid-lowering treatment (LLT) patterns is unclear. We assessed whether higher Lp(a) levels were associated with recorded post-test changes in lipid-lowering therapy (LLT). This retrospective obser...